CD274 and hepatocellular carcinoma: Interestingly, surviving mice (at day 46) receiving pAb HCC (alone or with anti–PD-L1), but not mice treated with anti–PD-L1 alone, mounted a murine anti-HCC IgG antibody response in their serum, indicating that the tumor had been made visible for the adaptative mouse immune system (Figure 4D).